Johnson & Johnson hit with $8 billion jury verdict in Risperdal suit

Source: Mihir Zaveri & Katie Thomas, New York Times (Paid Registration)

A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.

Read Full Article: Johnson & Johnson hit with $8 billion jury verdict in Risperdal suit

 

Tags/Keywords

 

Search

Quick Menu

Facebook FTwitter T
 

Consumer Help Desk

Advocacy